Francis Adu-Amankwaah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Francis Adu-Amankwaah has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Kudakwashe Nyambo
3 shared publications- Kudzanai Ian Tapfuma
Stellenbosch University, South Africa
3 shared publications Lawrence Mabasa
3 shared publications- Lucinda Baatjies
South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7505, South Africa
3 shared publications - Vuyo Mavumengwana
South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University
3 shared publications - Bienyameen Baker
DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
2 shared publications
Latest Publications
- 9 December 2025
- Published by Springer Nature in Archives of Microbiology
- Vol. 208 (1) , 54
Molecular links between tuberculosis and lung cancer: pathogenesis and therapeutic challenges
Tuberculosis (TB) and lung cancer, two leading global health burdens, increasingly coexist, particularly in high-burden regions of these diseases. Epidemiological studies suggest TB significantly elevates lung cancer risk, as lung cancer increases the risk of TB, yet the molecular basis of this association remains underexplored. TB-induced chronic inflammation, oxidative stress, epithelial-mesenchymal transition (EMT), and immune checkpoint dysregulation create a permissive environment for oncogenesis. Granulomas and tumour microenvironments share immunosuppressive features, while overlapping host genetic and epigenetic signatures exacerbate diagnostic complexity. Immunotherapy in cancer risks TB reactivation, highlighting clinical tensions. Understanding the TB-lung cancer molecular interface is essential for developing integrated diagnostics and safe treatment regimens. This review integrates current evidence on the overlapping pathogenic, immunological and molecular landscapes of TB and lung cancer to identify shared mechanisms, diagnostic dilemmas and therapeutic challenges, while highlighting significant gaps needing actionable interventions. We also suggest some future paradigm shifts toward dual-disease research frameworks, critical to advance care in TB-endemic regions.
- 9 December 2025
- Published by Springer Nature in Archives of Microbiology
- Vol. 208 (1) , 54
Molecular links between tuberculosis and lung cancer: pathogenesis and therapeutic challenges
Tuberculosis (TB) and lung cancer, two leading global health burdens, increasingly coexist, particularly in high-burden regions of these diseases. Epidemiological studies suggest TB significantly elevates lung cancer risk, as lung cancer increases the risk of TB, yet the molecular basis of this association remains underexplored. TB-induced chronic inflammation, oxidative stress, epithelial-mesenchymal transition (EMT), and immune checkpoint dysregulation create a permissive environment for oncogenesis. Granulomas and tumour microenvironments share immunosuppressive features, while overlapping host genetic and epigenetic signatures exacerbate diagnostic complexity. Immunotherapy in cancer risks TB reactivation, highlighting clinical tensions. Understanding the TB-lung cancer molecular interface is essential for developing integrated diagnostics and safe treatment regimens. This review integrates current evidence on the overlapping pathogenic, immunological and molecular landscapes of TB and lung cancer to identify shared mechanisms, diagnostic dilemmas and therapeutic challenges, while highlighting significant gaps needing actionable interventions. We also suggest some future paradigm shifts toward dual-disease research frameworks, critical to advance care in TB-endemic regions.
- Open Access
Therapeutic potential of IFIT2 in human diseases
- Open Access
- 17 January 2025
- Published by Elsevier in South African Journal of Botany
- Vol. 178, 73-88
Targeting mitochondrial function to inhibit glycolysis and oxidative phosphorylation (OXPHOS) for therapeutic intervention in triple-negative breast cancer line (MDA-MB 231) utilising Cape fynbos
- 17 January 2025
- Published by Elsevier in South African Journal of Botany
- Vol. 178, 73-88
Open AccessTargeting mitochondrial function to inhibit glycolysis and oxidative phosphorylation (OXPHOS) for therapeutic intervention in triple-negative breast cancer line (MDA-MB 231) utilising Cape fynbos
- Open Access
- 29 November 2024
- Published by Elsevier in Phytomedicine Plus
- Vol. 5 (1)
Phytochemical and pharmacological review of Erica Genus (L.) Ericaceae plants
- 29 November 2024
- Published by Elsevier in Phytomedicine Plus
- Vol. 5 (1)
Open AccessPhytochemical and pharmacological review of Erica Genus (L.) Ericaceae plants
- Open Access
- 21 June 2023
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 23 (1) , 1-12
Antimicrobial, antioxidant activities, and total phenolic contents of Pycnanthus angolensis Sap and Cryptolepis sanguinolenta root extracts
The death of many people in tropical countries can be attributed to microbial infection, probably, because synthetic antibiotics are failing in the treatment of most microbial infections, attributed to the ability of the microorganisms to mutate and adapt to harsh conditions. This study evaluated, in vitro, the antimicrobial activities, antioxidant potentials, and the total phenolic as well as phytochemical contents of aqueous and ethanol extracts of the root of Cryptolepis sanguinolenta (Lindl.) and the crude sap of Pycnanthus angolensis (Welw) using selected standard bacteria strains (Staphylococcus aureus (ATCC 25,923), Staphylococcus saprophyticus (ATCC 15,305), Escherichia coli (ATCC 25,922), Salmonella typhi (ATCC 19,430), Pseudomonas aeruginosa (ATCC 27,853), and Proteus mirabilis (ATCC 49,565). The modified agar well diffusion method was used to evaluate the antimicrobial activities of the plant extracts. Chloramphenicol and tetracycline were used as positive controls. The extracts were screened for specific phytochemicals with total phenolic contents were determined using Folin Ciocalteu reagent test. The phytoconstituents observed were alkaloids, cardiac glycosides, and saponins in both Cryptolepis sanguinolenta and Pycnanthus angolensis. For the antimicrobial activities, all the test bacteria were susceptible to the crude sap of Pycnanthus angolensis except Proteus mirabilis. In the case of the Cryptolepis sanguinolenta, only S. aureus was susceptible to both aqueous and ethanol extracts. The total phenolic content, expressed in g/100 g GAE, recorded values of 55.427 ± 4.248 for the crude sap of Pycnanthus angolensis, and 11.642 ± 4.248 and 26.888 ± 4.248 for the aqueous and ethanol extracts of Cryptolepis sanguinolenta, respectively. It is concluded that Cryptolepis sanguinolenta and Pycnanthus angolensis are excellent candidates for further development of antimicrobial agents in the fight against microbial infections given the pressing need for novel efficacious agents.
- 21 June 2023
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 23 (1) , 1-12
Open AccessAntimicrobial, antioxidant activities, and total phenolic contents of Pycnanthus angolensis Sap and Cryptolepis sanguinolenta root extracts
The death of many people in tropical countries can be attributed to microbial infection, probably, because synthetic antibiotics are failing in the treatment of most microbial infections, attributed to the ability of the microorganisms to mutate and adapt to harsh conditions. This study evaluated, in vitro, the antimicrobial activities, antioxidant potentials, and the total phenolic as well as phytochemical contents of aqueous and ethanol extracts of the root of Cryptolepis sanguinolenta (Lindl.) and the crude sap of Pycnanthus angolensis (Welw) using selected standard bacteria strains (Staphylococcus aureus (ATCC 25,923), Staphylococcus saprophyticus (ATCC 15,305), Escherichia coli (ATCC 25,922), Salmonella typhi (ATCC 19,430), Pseudomonas aeruginosa (ATCC 27,853), and Proteus mirabilis (ATCC 49,565). The modified agar well diffusion method was used to evaluate the antimicrobial activities of the plant extracts. Chloramphenicol and tetracycline were used as positive controls. The extracts were screened for specific phytochemicals with total phenolic contents were determined using Folin Ciocalteu reagent test. The phytoconstituents observed were alkaloids, cardiac glycosides, and saponins in both Cryptolepis sanguinolenta and Pycnanthus angolensis. For the antimicrobial activities, all the test bacteria were susceptible to the crude sap of Pycnanthus angolensis except Proteus mirabilis. In the case of the Cryptolepis sanguinolenta, only S. aureus was susceptible to both aqueous and ethanol extracts. The total phenolic content, expressed in g/100 g GAE, recorded values of 55.427 ± 4.248 for the crude sap of Pycnanthus angolensis, and 11.642 ± 4.248 and 26.888 ± 4.248 for the aqueous and ethanol extracts of Cryptolepis sanguinolenta, respectively. It is concluded that Cryptolepis sanguinolenta and Pycnanthus angolensis are excellent candidates for further development of antimicrobial agents in the fight against microbial infections given the pressing need for novel efficacious agents.
- Open Access
- 7 March 2023
- Published by Springer Nature in Research Square
Antimicrobial activities and total phenolic contents of the sap of Pycnanthus angolensis and root of Cryptolepis sanguinolenta
The death of many people in tropical countries can be attributed to microbial infection, probably, because synthetic antibiotics are failing in the treatment of these microbial infections, attributed to the ability of the microorganisms to mutate and adapt to harsh conditions. This study evaluated, in vitro, the antimicrobial activities, antioxidant potentials, and the total phenolic contents of aqueous and ethanol extracts of the root of Cryptolepis sanguinolenta (Lindl.) and the crude sap of Pycnanthus angolensis (Welw) using selected standard bacteria strains (S. aureus (ATCC 25923), S. saprophyticus (ATCC 15305), E. coli (ATCC 25922), S. typhi (ATCC 19430), P. aeruginosa (ATCC 27853), and P. mirabilis (ATCC 49565). The modified agar well diffusion method was used to evaluate the antimicrobial activities of the plant extracts. Chloramphenicol and tetracycline were used as positive controls. The extracts were also screened for specific phytochemicals and using the Folin Ciocalteu reagent test, their total phenolic contents were determined. The phytochemical screening revealed the presence of alkaloids, cardiac glycosides, and saponins in both Cryptolepis sanguinolenta and Pycnanthus angolensis. For the antimicrobial activities, all the test bacteria were susceptible to the crude sap of Pycnanthus angolensis except P. mirabilis. In the case of the Cryptolepis sanguinolenta, only S. aureus was susceptible to both aqueous and ethanol extracts. The total phenolic content, expressed in g/100g GAE, recorded values of 55.427 ± 4.248 for the crude sap of Pycnanthus angolensis, and 11.642 ± 4.248 and 26.888 ± 4.248 for the aqueous and ethanol extracts of Cryptolepis sanguinolenta, respectively. It was concluded that Cryptolepis sanguinolenta and Pycnanthus angolensis are excellent candidates for further development of antimicrobial agents in the fight against microbial infections given the pressing need for novel efficacious agents.
- 7 March 2023
- Published by Springer Nature in Research Square
Open AccessAntimicrobial activities and total phenolic contents of the sap of Pycnanthus angolensis and root of Cryptolepis sanguinolenta
The death of many people in tropical countries can be attributed to microbial infection, probably, because synthetic antibiotics are failing in the treatment of these microbial infections, attributed to the ability of the microorganisms to mutate and adapt to harsh conditions. This study evaluated, in vitro, the antimicrobial activities, antioxidant potentials, and the total phenolic contents of aqueous and ethanol extracts of the root of Cryptolepis sanguinolenta (Lindl.) and the crude sap of Pycnanthus angolensis (Welw) using selected standard bacteria strains (S. aureus (ATCC 25923), S. saprophyticus (ATCC 15305), E. coli (ATCC 25922), S. typhi (ATCC 19430), P. aeruginosa (ATCC 27853), and P. mirabilis (ATCC 49565). The modified agar well diffusion method was used to evaluate the antimicrobial activities of the plant extracts. Chloramphenicol and tetracycline were used as positive controls. The extracts were also screened for specific phytochemicals and using the Folin Ciocalteu reagent test, their total phenolic contents were determined. The phytochemical screening revealed the presence of alkaloids, cardiac glycosides, and saponins in both Cryptolepis sanguinolenta and Pycnanthus angolensis. For the antimicrobial activities, all the test bacteria were susceptible to the crude sap of Pycnanthus angolensis except P. mirabilis. In the case of the Cryptolepis sanguinolenta, only S. aureus was susceptible to both aqueous and ethanol extracts. The total phenolic content, expressed in g/100g GAE, recorded values of 55.427 ± 4.248 for the crude sap of Pycnanthus angolensis, and 11.642 ± 4.248 and 26.888 ± 4.248 for the aqueous and ethanol extracts of Cryptolepis sanguinolenta, respectively. It was concluded that Cryptolepis sanguinolenta and Pycnanthus angolensis are excellent candidates for further development of antimicrobial agents in the fight against microbial infections given the pressing need for novel efficacious agents.
- Open Access
- 25 August 2022
- Published by Elsevier in South African Journal of Botany
- Vol. 150, 702-710
Cytotoxic activity of Cape Fynbos against triple-negative breast cancer cell line
- 25 August 2022
- Published by Elsevier in South African Journal of Botany
- Vol. 150, 702-710
Open AccessCytotoxic activity of Cape Fynbos against triple-negative breast cancer cell line